Riskpilot← Back to searchSign inGet full accessAMEL AB
ABActiveOrg 5593667057Västanågatan 21General medical practice activities · NACE 8621Est. 20220 employees
Revenue 2025
SEK 465K
-1% vs 2024
EBITDA margin
76.1%
-21% vs 2024
Equity ratio
91.7%
Financial strength
Net profit 2025
SEK 275K
-23% vs 2024
| Revenue | SEK 465K | -1% |
| EBITDA | SEK 353K | -21% |
| Net profit | SEK 275K | -23% |
| Total assets | SEK 1,5M | +14% |
| Equity | SEK 1,4M | +26% |
| Employees | 0 | — |
Legal name
AMEL AB
Org number
5593667057
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
21 februari 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-10-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Hälso- och sjukvård jämte informations- och konsultationsverksamhet samt framställning av produkter, tjänster inom hälso- och sjukvård, försäljning och uthyrning inom dessa och angränsande områden såsom sport- och fritidssektorn.
Address
Västanågatan 21
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 269 | 269 | 931 | 469 | 465 |
| Staff expenses | — | −16 | — | −7 | −0 |
| EBITDA | 192 | 192 | 682 | 449 | 353 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 192 | 192 | 682 | 449 | 353 |
| Net financials | — | 0 | — | 1 | −5 |
| Profit before tax | 192 | 192 | 681 | 450 | 348 |
| Tax | −40 | 0 | −140 | −93 | −73 |
| Net profit | 152 | 152 | 541 | 357 | 275 |
| Item | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 253 | 253 | 904 | 1 287 | 1 473 |
| Equity | 177 | 177 | 719 | 1 076 | 1 351 |
| Long-term debt | 1 | 1 | 1 | 1 | 1 |
| Short-term debt | 75 | 75 | 185 | 211 | 121 |
| Total debt | 76 | 76 | 186 | 211 | 122 |
EBITDA margin
76.1%
This company
15.8%
Market median
+382% vs market
20222025
Equity ratio
91.7%
This company
38.2%
Market median
+140% vs market
20222025
Return on equity
20.4%
This company
18.4%
Market median
+11% vs market
20222025
Net profit margin
59.3%
This company
8.1%
Market median
+632% vs market
20222025
Asset turnover
0.32×
This company
1.12×
Market median
-71% vs market
20222025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-11-01 – 2025-10-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-11-01 – 2023-10-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-02-21 – 2022-10-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-02-01 – 2022-10-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
AM Chief Executive Officer | Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AMEL AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Armend Mehmeti | Deputy Chief Executive Officer | 0 companies |
| Adnan Mehmeti | Chief Executive Officer | 0 companies |